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Stephen P Povoski1* and Nathan C Hall2Cancer, far more than any other disease entity, requires
a multidisciplinary approach. This multidisciplinary ap-
proach to cancer involves the integration of treatment
strategies specifically set forth by surgical oncologists,
medical oncologists, and radiation oncologists [1-3].
While early stage solid malignancies are frequently
treated successfully with surgical therapy alone, higher-
stage disease generally requires integration of surgery
along with adjuvant therapies that are administered by
the medical oncologists and/or radiation oncologists,
both in a standard postoperative fashion, as well as in a
preoperative/neoadjuvant fashion. Treatment planning
and treatment implementation by surgical oncologists,
medical oncologists, and radiation oncologists rely heav-
ily on various cancer imaging modalities [4-10]. There-
fore, integral to each of these cancer subspecialists is the
critical role played by the cancer imaging physician.
Realistically, none of these cancer subspecialists can
work in a vacuum, and such integration of services is es-
sential for optimizing success of treatment, minimizing
complications, and impacting positively on long-term
outcome.
BMC Cancer, which was conceived in January 2001
[11,12], has made enormous efforts to consider articles
addressing all aspects of cancer basic science and clinical
research, including articles that address pathophysiology,
prevention, diagnosis, and treatment. However, BMC
Cancer also recognizes that while submissions
concerning molecular and cellular biology, genetics, epi-
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distribution, and reproduction in any mediumclinical trials related to medical oncologists and radi-
ation oncologists have been well-represented, to the con-
trary, submissions concerning areas of interest to
surgical oncologists and cancer imaging physicians have
been far underrepresented. Therefore, in an effort to
help reach out to and expand the surgical oncology and
cancer imaging readership, BMC Cancer is introducing a
new sub-section within the current “Clinical oncology”
section that will be entitled “Surgical oncology and im-
aging”. It is hopeful that this new sub-section will be an
important area of future scholarly growth for BMC
Cancer.
Within the past several years, increasing interest has
developed in attempting to maximize the integration of
cancer imaging into the surgical treatment schema for
solid malignancies [13,14]. The development of such a
multimodal approach has been the driving force of our
own multidisciplinary cancer detection and therapy
group at The Ohio State University [14]. It has been our
ongoing contention that such a multimodal approach to
cancer detection and surgical treatment is critical for
diagnostic accuracy, surgical planning, intraoperative
identification of all diseased tissues, guidance of surgical
resection, and verification of the completeness of the
surgical resection. Additionally, a multimodal approach
to cancer detection and surgical treatment allows for
complete integration and coordination of services pro-
vided by physicians involved in the surgical management
of cancer patients, including surgical oncologists, cancer
imaging physicians, and pathologists [14-18]. It is our
hope that the efforts of BMC Cancer to reach out to the
surgical oncology and cancer imaging readership will en-
able further development and refinement of such multi-
modal approaches to cancer detection and surgical
treatment. Furthermore, with the ongoing development
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concept of a multimodal approach will ultimately en-
compass preoperative and perioperative cancer imaging,
intraoperative cancer detection and surgical resection,
postoperative and long-term surveillance cancer im-
aging, and a wide variety of potential adjuvant target-
specific and antigen-specific cancer therapies [19]. Such
an integrated multimodal approach holds much promise
for ultimately improving the care and long-term out-
come of future cancer patients.
In summary, we enthusiastically welcome the efforts
put forward by BMC Cancer in reaching out to the sur-
gical oncology and cancer imaging readership by the
introduction of the “Surgical oncology and imaging”
sub-section. We envision this to become an important
area of future scholarly growth for BMC Cancer and
look forward to receiving submissions in this area.
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